David Braun Receives the Dr. Christopher G. Wood Rising Star Award
David Braun has been honored with the Dr. Christopher G. Wood Rising Star Award
The award recognizes junior-level faculty making significant contributions to kidney cancer research, treatment, and education. Dr. Braun’s innovative work and commitment to advancing patient care align with Dr. Wood’s legacy of mentoring and shaping the next generation of kidney cancer professionals. As the recipient of this esteemed award, Dr. Braun is recognized for his promise as a future leader in the field.
About Christopher G. Wood Rising Star Award
The Christopher G. Wood Rising Star Award, established through the Dr. Christopher G. Wood Endowment, honors Dr. Wood’s legacy in advancing kidney cancer research, education, and patient care. The award is presented annually at IKCS: North America and IKCS: Europe to a junior-level faculty member who demonstrates exceptional promise in the kidney cancer field.
This prestigious award recognizes individuals who show dedication to innovation, clinical practice, and mentoring in kidney cancer, mirroring Dr. Wood’s passion for supporting the next generation of providers. Dr. Wood was known for his leadership, collaboration, and commitment to improving patient outcomes, and the Rising Star Award continues that tradition by encouraging young professionals to build on his groundbreaking work.
The Dr. Christopher G. Wood Endowment, funded by generous donations, ensures this award continues to inspire and uplift emerging talent, strengthening the future of kidney cancer care and research.
About David Braun
David Braun, MD, PhD, is an Assistant Professor of Medicine in the Division of Medical Oncology and a member of the Center for Molecular and Cellular Oncology (CMCO) at Yale Cancer Center. Specializing in the treatment of kidney cancer, Dr. Braun has a strong background in both clinical care and research. He earned his PhD in Computational Biology from the Courant Institute of Mathematical Sciences at New York University and his medical degree from the Icahn School of Medicine at Mount Sinai.
After completing his residency at Brigham and Women’s Hospital, where he received the Dunn Medical Intern Award and served as Chief Medical Resident, he went on to train in adult oncology through the Dana-Farber/Partners Cancer Care program. During his fellowship, he was honored as the Emil Frei Fellow and the John R. Svenson Fellow.
Dr. Braun was an Instructor in Medicine at Dana-Farber Cancer Institute, where his clinical and research focus centered on improving immune therapies for kidney cancer. He has a long-standing interest in integrating experimental and computational approaches to cancer research.
His current work explores the mechanisms behind response and resistance to immune therapies in kidney cancer, aiming to develop innovative new treatments. As part of the CMCO at Yale, Dr. Braun continues to mentor the next generation of physician-scientists, helping to bridge laboratory research with clinical applications to improve cancer diagnosis and treatment.
KCA:
“Congratulations to David Braun for receiving the KCA’s Christopher G. Wood Rising Star Award!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023